Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
18401
18402
18403
18404
18405
18406
18407
18408
18409
18410
18411
18412
18413
18414
18415
18416
18417
18418
18419
18420
18421
18422
18423
18424
18425
18426
18427
18428
18429
18430
18431
18432
18433
18434
18435
18436
18437
18438
18439
18440
18441
18442
18443
18444
18445
18446
18447
18448
18449
18450
18451
18452
18453
18454
18455
18456
18457
18458
18459
18460
18461
18462
18463
18464
18465
18466
18467
18468
18469
18470
18471
18472
18473
18474
18475
18476
18477
18478
18479
18480
18481
18482
18483
18484
18485
18486
18487
18488
18489
18490
18491
18492
18493
18494
18495
18496
18497
18498
18499
18500
18501
18502
18503
18504
18505
18506
18507
18508
18509
18510
18511
18512
18513
18514
18515
18516
18517
18518
18519
18520
18521
18522
18523
18524
18525
18526
18527
18528
18529
18530
18531
18532
18533
18534
18535
18536
18537
18538
18539
18540
18541
18542
18543
18544
18545
18546
18547
18548
18549
18550
18551
18552
18553
18554
18555
18556
18557
18558
18559
18560
18561
18562
18563
18564
18565
18566
18567
18568
18569
18570
18571
18572
18573
18574
18575
18576
18577
18578
18579
18580
18581
18582
18583
18584
18585
18586
18587
18588
18589
18590
18591
18592
18593
18594
18595
18596
18597
18598
18599
18600
| UnnamedSample_HQ_transcript/13584|m.4978 | UnnamedSample_HQ_transcript/13584 | Coverage 0.278 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF01699 | Sodium/calcium exchanger protein | 41 | 225 | 2.5E-24 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/16197|m.5768 | UnnamedSample_HQ_transcript/16197 | Coverage 0.359 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF03160 | Calx-beta domain | 467 | 564 | 7.3E-22 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/16197|m.5768 | UnnamedSample_HQ_transcript/16197 | Coverage 0.359 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF03160 | Calx-beta domain | 357 | 449 | 1.2E-21 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/16197|m.5768 | UnnamedSample_HQ_transcript/16197 | Coverage 0.359 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF01699 | Sodium/calcium exchanger protein | 662 | 826 | 2.6E-17 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/16197|m.5768 | UnnamedSample_HQ_transcript/16197 | Coverage 0.359 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF01699 | Sodium/calcium exchanger protein | 41 | 225 | 2.5E-24 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/20415|m.6979 | UnnamedSample_HQ_transcript/20415 | Coverage 0.163 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF03160 | Calx-beta domain | 467 | 564 | 7.3E-22 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/20415|m.6979 | UnnamedSample_HQ_transcript/20415 | Coverage 0.163 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF03160 | Calx-beta domain | 357 | 449 | 1.2E-21 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/20415|m.6979 | UnnamedSample_HQ_transcript/20415 | Coverage 0.163 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF01699 | Sodium/calcium exchanger protein | 662 | 826 | 2.6E-17 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/20415|m.6979 | UnnamedSample_HQ_transcript/20415 | Coverage 0.163 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF01699 | Sodium/calcium exchanger protein | 41 | 225 | 2.5E-24 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/20475|m.6999 | UnnamedSample_HQ_transcript/20475 | Coverage 0.312 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF03160 | Calx-beta domain | 467 | 564 | 7.3E-22 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/20475|m.6999 | UnnamedSample_HQ_transcript/20475 | Coverage 0.312 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF03160 | Calx-beta domain | 357 | 449 | 1.2E-21 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/20475|m.6999 | UnnamedSample_HQ_transcript/20475 | Coverage 0.312 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF01699 | Sodium/calcium exchanger protein | 662 | 826 | 2.6E-17 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/20475|m.6999 | UnnamedSample_HQ_transcript/20475 | Coverage 0.312 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF01699 | Sodium/calcium exchanger protein | 41 | 225 | 2.5E-24 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/28420|m.9076 | UnnamedSample_HQ_transcript/28420 | Coverage 0.190 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF03160 | Calx-beta domain | 467 | 564 | 7.3E-22 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/28420|m.9076 | UnnamedSample_HQ_transcript/28420 | Coverage 0.190 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF03160 | Calx-beta domain | 357 | 449 | 1.2E-21 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/28420|m.9076 | UnnamedSample_HQ_transcript/28420 | Coverage 0.190 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF01699 | Sodium/calcium exchanger protein | 662 | 826 | 2.6E-17 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/28420|m.9076 | UnnamedSample_HQ_transcript/28420 | Coverage 0.190 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF01699 | Sodium/calcium exchanger protein | 41 | 225 | 2.5E-24 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/19940|m.6852 | UnnamedSample_HQ_transcript/19940 | Coverage 0.310 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF03160 | Calx-beta domain | 467 | 564 | 7.3E-22 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/19940|m.6852 | UnnamedSample_HQ_transcript/19940 | Coverage 0.310 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF03160 | Calx-beta domain | 357 | 449 | 1.2E-21 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/19940|m.6852 | UnnamedSample_HQ_transcript/19940 | Coverage 0.310 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF01699 | Sodium/calcium exchanger protein | 662 | 826 | 2.6E-17 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/19940|m.6852 | UnnamedSample_HQ_transcript/19940 | Coverage 0.310 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF01699 | Sodium/calcium exchanger protein | 41 | 225 | 2.5E-24 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/15156|m.5448 | UnnamedSample_HQ_transcript/15156 | Coverage 0.282 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF03160 | Calx-beta domain | 467 | 564 | 7.3E-22 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/15156|m.5448 | UnnamedSample_HQ_transcript/15156 | Coverage 0.282 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF03160 | Calx-beta domain | 357 | 449 | 1.2E-21 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/15156|m.5448 | UnnamedSample_HQ_transcript/15156 | Coverage 0.282 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF01699 | Sodium/calcium exchanger protein | 662 | 826 | 2.6E-17 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/15156|m.5448 | UnnamedSample_HQ_transcript/15156 | Coverage 0.282 too low. | b999de73b81972b97a455bb5b7ab5149 | 837 | Pfam | PF01699 | Sodium/calcium exchanger protein | 41 | 225 | 2.5E-24 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/211|m.188 | UnnamedSample_HQ_transcript/211 | Identity 0.933 too low. | 4cfc26bf18c92088fba5f7f143152c96 | 2797 | Pfam | PF09172 | Domain of unknown function (DUF1943) | 665 | 972 | 4.4E-51 | T | 22-09-2020 | IPR015255 | Vitellinogen, open beta-sheet |
| UnnamedSample_HQ_transcript/211|m.188 | UnnamedSample_HQ_transcript/211 | Identity 0.933 too low. | 4cfc26bf18c92088fba5f7f143152c96 | 2797 | Pfam | PF01347 | Lipoprotein amino terminal region | 81 | 633 | 3.5E-60 | T | 22-09-2020 | IPR001747 | Lipid transport protein, N-terminal |
| UnnamedSample_HQ_transcript/79259|m.19591 | UnnamedSample_HQ_transcript/79259 | Coverage 0.975 too low. | 40d503faa4ba2ccbbaa5fd303db918bb | 291 | Pfam | PF00780 | CNH domain | 4 | 261 | 4.9E-56 | T | 22-09-2020 | IPR001180 | Citron homology (CNH) domain |
| UnnamedSample_HQ_transcript/30986|m.9708 | UnnamedSample_HQ_transcript/30986 | Coverage 0.987 too low. | 40d503faa4ba2ccbbaa5fd303db918bb | 291 | Pfam | PF00780 | CNH domain | 4 | 261 | 4.9E-56 | T | 22-09-2020 | IPR001180 | Citron homology (CNH) domain |
| UnnamedSample_HQ_transcript/9678|m.3723 | UnnamedSample_HQ_transcript/9678 | Coverage 0.934 too low. | aa1a915947d3c528fc631fae1b933a12 | 1282 | Pfam | PF12624 | N-terminal region of Chorein or VPS13 | 3 | 96 | 4.4E-18 | T | 22-09-2020 | IPR026854 | Vacuolar protein sorting-associated protein 13-like, N-terminal domain |
| UnnamedSample_HQ_transcript/2929|m.1422 | UnnamedSample_HQ_transcript/2929 | Coverage 0.904 too low. | aa1a915947d3c528fc631fae1b933a12 | 1282 | Pfam | PF12624 | N-terminal region of Chorein or VPS13 | 3 | 96 | 4.4E-18 | T | 22-09-2020 | IPR026854 | Vacuolar protein sorting-associated protein 13-like, N-terminal domain |
| UnnamedSample_HQ_transcript/6264|m.2625 | UnnamedSample_HQ_transcript/6264 | Coverage 0.886 too low. | aa1a915947d3c528fc631fae1b933a12 | 1282 | Pfam | PF12624 | N-terminal region of Chorein or VPS13 | 3 | 96 | 4.4E-18 | T | 22-09-2020 | IPR026854 | Vacuolar protein sorting-associated protein 13-like, N-terminal domain |
| UnnamedSample_HQ_transcript/3232|m.1534 | UnnamedSample_HQ_transcript/3232 | Coverage 0.917 too low. | aa1a915947d3c528fc631fae1b933a12 | 1282 | Pfam | PF12624 | N-terminal region of Chorein or VPS13 | 3 | 96 | 4.4E-18 | T | 22-09-2020 | IPR026854 | Vacuolar protein sorting-associated protein 13-like, N-terminal domain |
| UnnamedSample_HQ_transcript/7995|m.3181 | UnnamedSample_HQ_transcript/7995 | Coverage 0.885 too low. | aa1a915947d3c528fc631fae1b933a12 | 1282 | Pfam | PF12624 | N-terminal region of Chorein or VPS13 | 3 | 96 | 4.4E-18 | T | 22-09-2020 | IPR026854 | Vacuolar protein sorting-associated protein 13-like, N-terminal domain |
| UnnamedSample_HQ_transcript/3015|m.1450 | UnnamedSample_HQ_transcript/3015 | Coverage 0.936 too low. | b3e225d87c8f2046f0545635e0469d50 | 1143 | Pfam | PF01388 | ARID/BRIGHT DNA binding domain | 900 | 987 | 2.1E-18 | T | 22-09-2020 | IPR001606 | ARID DNA-binding domain |
| UnnamedSample_HQ_transcript/107303|m.23497 | UnnamedSample_HQ_transcript/107303 | Identity 0.919 too low. | 6473a8776a208e1d516e7403ef1ef652 | 298 | Pfam | PF13639 | Ring finger domain | 48 | 90 | 9.1E-11 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/4238|m.1892 | UnnamedSample_HQ_transcript/4238 | Coverage 0.925 too low. | 5ad659ab72497dc60b46a69d613b0d23 | 1156 | Pfam | PF02181 | Formin Homology 2 Domain | 667 | 1041 | 1.0E-110 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/4238|m.1892 | UnnamedSample_HQ_transcript/4238 | Coverage 0.925 too low. | 5ad659ab72497dc60b46a69d613b0d23 | 1156 | Pfam | PF06367 | Diaphanous FH3 Domain | 295 | 482 | 1.5E-58 | T | 22-09-2020 | IPR010472 | Formin, FH3 domain |
| UnnamedSample_HQ_transcript/4238|m.1892 | UnnamedSample_HQ_transcript/4238 | Coverage 0.925 too low. | 5ad659ab72497dc60b46a69d613b0d23 | 1156 | Pfam | PF06371 | Diaphanous GTPase-binding Domain | 104 | 292 | 3.5E-44 | T | 22-09-2020 | IPR010473 | Formin, GTPase-binding domain |
| UnnamedSample_HQ_transcript/76815|m.19174 | UnnamedSample_HQ_transcript/76815 | Coverage 0.073 too low. | bb9bc85cede52b72f8daeaff9216231b | 491 | Pfam | PF08662 | Eukaryotic translation initiation factor eIF2A | 172 | 367 | 3.9E-78 | T | 22-09-2020 | IPR013979 | Translation initiation factor, beta propellor-like domain |
| UnnamedSample_HQ_transcript/95103|m.21968 | UnnamedSample_HQ_transcript/95103 | Coverage 0.988 too low. | 4f5dc0687cf2d6d24b1cd23d98ba8c7b | 342 | Pfam | PF08572 | pre-mRNA processing factor 3 (PRP3) | 207 | 342 | 1.9E-30 | T | 22-09-2020 | IPR013881 | Pre-mRNA-splicing factor 3 |
| UnnamedSample_HQ_transcript/59919|m.16038 | UnnamedSample_HQ_transcript/59919 | Coverage 0.893 too low. | d381f6ebbda5ba0e8d272d802b1f16a8 | 571 | Pfam | PF00732 | GMC oxidoreductase | 7 | 306 | 2.1E-74 | T | 22-09-2020 | IPR000172 | Glucose-methanol-choline oxidoreductase, N-terminal |
| UnnamedSample_HQ_transcript/59919|m.16038 | UnnamedSample_HQ_transcript/59919 | Coverage 0.893 too low. | d381f6ebbda5ba0e8d272d802b1f16a8 | 571 | Pfam | PF05199 | GMC oxidoreductase | 413 | 557 | 1.6E-38 | T | 22-09-2020 | IPR007867 | Glucose-methanol-choline oxidoreductase, C-terminal |
| UnnamedSample_HQ_transcript/51521|m.14356 | UnnamedSample_HQ_transcript/51521 | Coverage 0.738 too low. | 8e63ed5006389f831281f741e931ecaf | 268 | Pfam | PF03188 | Eukaryotic cytochrome b561 | 81 | 215 | 2.2E-38 | T | 22-09-2020 | IPR006593 | Cytochrome b561/ferric reductase transmembrane |
| UnnamedSample_HQ_transcript/55040|m.15048 | UnnamedSample_HQ_transcript/55040 | Coverage 0.806 too low. | 8e63ed5006389f831281f741e931ecaf | 268 | Pfam | PF03188 | Eukaryotic cytochrome b561 | 81 | 215 | 2.2E-38 | T | 22-09-2020 | IPR006593 | Cytochrome b561/ferric reductase transmembrane |
| UnnamedSample_HQ_transcript/64982|m.17026 | UnnamedSample_HQ_transcript/64982 | Coverage 0.880 too low. | 8e63ed5006389f831281f741e931ecaf | 268 | Pfam | PF03188 | Eukaryotic cytochrome b561 | 81 | 215 | 2.2E-38 | T | 22-09-2020 | IPR006593 | Cytochrome b561/ferric reductase transmembrane |
| UnnamedSample_HQ_transcript/91771|m.21509 | UnnamedSample_HQ_transcript/91771 | Coverage 0.740 too low. | 8e63ed5006389f831281f741e931ecaf | 268 | Pfam | PF03188 | Eukaryotic cytochrome b561 | 81 | 215 | 2.2E-38 | T | 22-09-2020 | IPR006593 | Cytochrome b561/ferric reductase transmembrane |
| UnnamedSample_HQ_transcript/101147|m.22768 | UnnamedSample_HQ_transcript/101147 | Coverage 0.802 too low. | 8e63ed5006389f831281f741e931ecaf | 268 | Pfam | PF03188 | Eukaryotic cytochrome b561 | 81 | 215 | 2.2E-38 | T | 22-09-2020 | IPR006593 | Cytochrome b561/ferric reductase transmembrane |
| UnnamedSample_HQ_transcript/69811|m.17893 | UnnamedSample_HQ_transcript/69811 | Coverage 0.930 too low. | 8e63ed5006389f831281f741e931ecaf | 268 | Pfam | PF03188 | Eukaryotic cytochrome b561 | 81 | 215 | 2.2E-38 | T | 22-09-2020 | IPR006593 | Cytochrome b561/ferric reductase transmembrane |
| UnnamedSample_HQ_transcript/60357|m.16131 | UnnamedSample_HQ_transcript/60357 | Coverage 0.831 too low. | 8e63ed5006389f831281f741e931ecaf | 268 | Pfam | PF03188 | Eukaryotic cytochrome b561 | 81 | 215 | 2.2E-38 | T | 22-09-2020 | IPR006593 | Cytochrome b561/ferric reductase transmembrane |
| UnnamedSample_HQ_transcript/47411|m.13449 | UnnamedSample_HQ_transcript/47411 | Coverage 0.705 too low. | 8e63ed5006389f831281f741e931ecaf | 268 | Pfam | PF03188 | Eukaryotic cytochrome b561 | 81 | 215 | 2.2E-38 | T | 22-09-2020 | IPR006593 | Cytochrome b561/ferric reductase transmembrane |
| UnnamedSample_HQ_transcript/16701|m.5918 | UnnamedSample_HQ_transcript/16701 | Coverage 0.972 too low. | 1a8ceae51da07c87790c78464d1dacee | 561 | Pfam | PF14051 | N-terminal domain of DPF2/REQ. | 24 | 94 | 3.2E-36 | T | 22-09-2020 | IPR025750 | Requiem/DPF N-terminal domain |
| UnnamedSample_HQ_transcript/16701|m.5918 | UnnamedSample_HQ_transcript/16701 | Coverage 0.972 too low. | 1a8ceae51da07c87790c78464d1dacee | 561 | Pfam | PF00628 | PHD-finger | 510 | 556 | 9.3E-13 | T | 22-09-2020 | IPR019787 | Zinc finger, PHD-finger |
| UnnamedSample_HQ_transcript/19969|m.6863 | UnnamedSample_HQ_transcript/19969 | Identity 0.949 too low. | 1a8ceae51da07c87790c78464d1dacee | 561 | Pfam | PF14051 | N-terminal domain of DPF2/REQ. | 24 | 94 | 3.2E-36 | T | 22-09-2020 | IPR025750 | Requiem/DPF N-terminal domain |
| UnnamedSample_HQ_transcript/19969|m.6863 | UnnamedSample_HQ_transcript/19969 | Identity 0.949 too low. | 1a8ceae51da07c87790c78464d1dacee | 561 | Pfam | PF00628 | PHD-finger | 510 | 556 | 9.3E-13 | T | 22-09-2020 | IPR019787 | Zinc finger, PHD-finger |
| UnnamedSample_HQ_transcript/811|m.547 | UnnamedSample_HQ_transcript/811 | Identity 0.938 too low. | 6cb62cd5ff44def389100c24c9e6801f | 1655 | Pfam | PF15336 | Autism susceptibility gene 2 protein | 1165 | 1348 | 6.2E-7 | T | 22-09-2020 | IPR023246 | Autism susceptibility gene 2 protein |
| UnnamedSample_HQ_transcript/87936|m.20929 | UnnamedSample_HQ_transcript/87936 | Coverage 0.967 too low. | cc58295abb82459da067f87f39cd8c15 | 419 | Pfam | PF00498 | FHA domain | 19 | 90 | 1.4E-10 | T | 22-09-2020 | IPR000253 | Forkhead-associated (FHA) domain |
| UnnamedSample_HQ_transcript/33512|m.10338 | UnnamedSample_HQ_transcript/33512 | Identity 0.646 too low. | 7d7f2524feb7664b35c9a1b575cf0339 | 509 | Pfam | PF00501 | AMP-binding enzyme | 75 | 508 | 5.6E-66 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/31631|m.9860 | UnnamedSample_HQ_transcript/31631 | Identity 0.628 too low. | 7d7f2524feb7664b35c9a1b575cf0339 | 509 | Pfam | PF00501 | AMP-binding enzyme | 75 | 508 | 5.6E-66 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/4847|m.2133 | UnnamedSample_HQ_transcript/4847 | Coverage 0.742 too low. | 03a5852bbd32236cb5afc7aa1b5f7987 | 732 | Pfam | PF00621 | RhoGEF domain | 350 | 533 | 2.8E-39 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/4847|m.2133 | UnnamedSample_HQ_transcript/4847 | Coverage 0.742 too low. | 03a5852bbd32236cb5afc7aa1b5f7987 | 732 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 32 | 82 | 1.7E-11 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/4847|m.2133 | UnnamedSample_HQ_transcript/4847 | Coverage 0.742 too low. | 03a5852bbd32236cb5afc7aa1b5f7987 | 732 | Pfam | PF17838 | PH domain | 565 | 695 | 7.0E-30 | T | 22-09-2020 | IPR041020 | ARHGEF1-like, PH domain |
| UnnamedSample_HQ_transcript/20679|m.7059 | UnnamedSample_HQ_transcript/20679 | Coverage 0.831 too low. | 159ecf355eadac27b3f1e0757729585e | 964 | Pfam | PF00041 | Fibronectin type III domain | 239 | 315 | 2.6E-8 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/20679|m.7059 | UnnamedSample_HQ_transcript/20679 | Coverage 0.831 too low. | 159ecf355eadac27b3f1e0757729585e | 964 | Pfam | PF00041 | Fibronectin type III domain | 336 | 415 | 4.1E-7 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/20679|m.7059 | UnnamedSample_HQ_transcript/20679 | Coverage 0.831 too low. | 159ecf355eadac27b3f1e0757729585e | 964 | Pfam | PF00041 | Fibronectin type III domain | 448 | 523 | 2.4E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/20679|m.7059 | UnnamedSample_HQ_transcript/20679 | Coverage 0.831 too low. | 159ecf355eadac27b3f1e0757729585e | 964 | Pfam | PF00102 | Protein-tyrosine phosphatase | 873 | 963 | 1.5E-33 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/37285|m.11230 | UnnamedSample_HQ_transcript/37285 | Coverage 0.894 too low. | 6e9051c4cfcaca783f75cf9dc65642ad | 727 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 150 | 217 | 7.5E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/9579|m.3700 | UnnamedSample_HQ_transcript/9579 | Identity 0.633 too low. | a2229ed9183364eeb6863e38a72cfe49 | 1320 | Pfam | PF00041 | Fibronectin type III domain | 39 | 122 | 2.5E-12 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/9579|m.3700 | UnnamedSample_HQ_transcript/9579 | Identity 0.633 too low. | a2229ed9183364eeb6863e38a72cfe49 | 1320 | Pfam | PF00041 | Fibronectin type III domain | 1177 | 1250 | 5.6E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/9579|m.3700 | UnnamedSample_HQ_transcript/9579 | Identity 0.633 too low. | a2229ed9183364eeb6863e38a72cfe49 | 1320 | Pfam | PF07679 | Immunoglobulin I-set domain | 743 | 832 | 2.2E-19 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/9579|m.3700 | UnnamedSample_HQ_transcript/9579 | Identity 0.633 too low. | a2229ed9183364eeb6863e38a72cfe49 | 1320 | Pfam | PF07679 | Immunoglobulin I-set domain | 256 | 346 | 1.9E-17 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/9579|m.3700 | UnnamedSample_HQ_transcript/9579 | Identity 0.633 too low. | a2229ed9183364eeb6863e38a72cfe49 | 1320 | Pfam | PF07679 | Immunoglobulin I-set domain | 357 | 447 | 1.1E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/9579|m.3700 | UnnamedSample_HQ_transcript/9579 | Identity 0.633 too low. | a2229ed9183364eeb6863e38a72cfe49 | 1320 | Pfam | PF07679 | Immunoglobulin I-set domain | 591 | 683 | 9.6E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/9579|m.3700 | UnnamedSample_HQ_transcript/9579 | Identity 0.633 too low. | a2229ed9183364eeb6863e38a72cfe49 | 1320 | Pfam | PF07679 | Immunoglobulin I-set domain | 961 | 1045 | 2.7E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/9579|m.3700 | UnnamedSample_HQ_transcript/9579 | Identity 0.633 too low. | a2229ed9183364eeb6863e38a72cfe49 | 1320 | Pfam | PF07679 | Immunoglobulin I-set domain | 138 | 226 | 7.2E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/9579|m.3700 | UnnamedSample_HQ_transcript/9579 | Identity 0.633 too low. | a2229ed9183364eeb6863e38a72cfe49 | 1320 | Pfam | PF07679 | Immunoglobulin I-set domain | 852 | 940 | 5.5E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/9579|m.3700 | UnnamedSample_HQ_transcript/9579 | Identity 0.633 too low. | a2229ed9183364eeb6863e38a72cfe49 | 1320 | Pfam | PF07679 | Immunoglobulin I-set domain | 470 | 562 | 1.6E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/9579|m.3700 | UnnamedSample_HQ_transcript/9579 | Identity 0.633 too low. | a2229ed9183364eeb6863e38a72cfe49 | 1320 | Pfam | PF07679 | Immunoglobulin I-set domain | 1076 | 1161 | 2.3E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/88340|m.20989 | UnnamedSample_HQ_transcript/88340 | Coverage 0.548 too low. | 36e88d135f3859a8f542106aaed72c4b | 364 | Pfam | PF14497 | Glutathione S-transferase, C-terminal domain | 261 | 362 | 7.8E-22 | T | 22-09-2020 | IPR004046 | Glutathione S-transferase, C-terminal |
| UnnamedSample_HQ_transcript/88340|m.20989 | UnnamedSample_HQ_transcript/88340 | Coverage 0.548 too low. | 36e88d135f3859a8f542106aaed72c4b | 364 | Pfam | PF02798 | Glutathione S-transferase, N-terminal domain | 178 | 237 | 2.4E-10 | T | 22-09-2020 | IPR004045 | Glutathione S-transferase, N-terminal |
| UnnamedSample_HQ_transcript/86388|m.20706 | UnnamedSample_HQ_transcript/86388 | Coverage 0.107 too low. | 7b7c3f2c9cba716fe54a9bebb64bdf63 | 361 | Pfam | PF05485 | THAP domain | 23 | 109 | 6.9E-17 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/24329|m.8028 | UnnamedSample_HQ_transcript/24329 | Coverage 0.601 too low. | 7b7c3f2c9cba716fe54a9bebb64bdf63 | 361 | Pfam | PF05485 | THAP domain | 23 | 109 | 6.9E-17 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/55170|m.15072 | UnnamedSample_HQ_transcript/55170 | Coverage 0.953 too low. | e070494221ebc63eb91ac197d1a03a8f | 275 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 87 | 258 | 3.1E-43 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/14154|m.5154 | UnnamedSample_HQ_transcript/14154 | Coverage 0.176 too low. | 6edbdbea7103b474ace361811f0f8809 | 698 | Pfam | PF02145 | Rap/ran-GAP | 265 | 445 | 5.4E-70 | T | 22-09-2020 | IPR000331 | Rap GTPase activating protein domain |
| UnnamedSample_HQ_transcript/16515|m.5865 | UnnamedSample_HQ_transcript/16515 | Coverage 0.134 too low. | 6edbdbea7103b474ace361811f0f8809 | 698 | Pfam | PF02145 | Rap/ran-GAP | 265 | 445 | 5.4E-70 | T | 22-09-2020 | IPR000331 | Rap GTPase activating protein domain |
| UnnamedSample_HQ_transcript/42713|m.12420 | UnnamedSample_HQ_transcript/42713 | Coverage 0.883 too low. | 788fd83f38493dca01d46d8da0e7fbc6 | 397 | Pfam | PF00083 | Sugar (and other) transporter | 5 | 370 | 3.6E-40 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/57777|m.15609 | UnnamedSample_HQ_transcript/57777 | Identity 0.700 too low. | 9f86c4948366660dfcc50f98a207237a | 337 | Pfam | PF17800 | Nucleoplasmin-like domain | 23 | 68 | 1.1E-9 | T | 22-09-2020 | IPR041232 | Nucleoplasmin-like domain |
| UnnamedSample_HQ_transcript/109217|m.23739 | UnnamedSample_HQ_transcript/109217 | Coverage 0.984 too low. | 79ecb20239f742638dbdf8558bd61d9c | 218 | Pfam | PF13913 | zinc-finger of a C2HC-type | 14 | 37 | 2.0E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/109217|m.23739 | UnnamedSample_HQ_transcript/109217 | Coverage 0.984 too low. | 79ecb20239f742638dbdf8558bd61d9c | 218 | Pfam | PF13913 | zinc-finger of a C2HC-type | 114 | 136 | 3.0E-5 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/64149|m.16869 | UnnamedSample_HQ_transcript/64149 | Coverage 0.646 too low. | 3e5f4d042c1af8d691cfea74889a754a | 251 | Pfam | PF03381 | LEM3 (ligand-effect modulator 3) family / CDC50 family | 57 | 239 | 9.8E-49 | T | 22-09-2020 | IPR005045 | CDC50/LEM3 family |
| UnnamedSample_HQ_transcript/32598|m.10107 | UnnamedSample_HQ_transcript/32598 | Coverage 0.894 too low. | a1bf013e2e4a2ccf874a05cdee874430 | 617 | Pfam | PF00226 | DnaJ domain | 554 | 616 | 1.5E-14 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/32598|m.10107 | UnnamedSample_HQ_transcript/32598 | Coverage 0.894 too low. | a1bf013e2e4a2ccf874a05cdee874430 | 617 | Pfam | PF00012 | Hsp70 protein | 1 | 544 | 1.9E-176 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/28056|m.8985 | UnnamedSample_HQ_transcript/28056 | Coverage 0.985 too low. | 1c43a94caf2dfd259ec234dac87a7e54 | 408 | Pfam | PF16563 | Coiled-coil and interaction region of P66A and P66B with MBD2 | 107 | 144 | 2.9E-16 | T | 22-09-2020 | IPR032346 | Transcriptional repressor p66, coiled-coil MBD2-interaction domain |
| UnnamedSample_HQ_transcript/36981|m.11162 | UnnamedSample_HQ_transcript/36981 | Coverage 0.975 too low. | 5d79fcd5cbde196f3da437c5e891b8bc | 357 | Pfam | PF00390 | Malic enzyme, N-terminal domain | 1 | 32 | 4.9E-6 | T | 22-09-2020 | IPR012301 | Malic enzyme, N-terminal domain |
| UnnamedSample_HQ_transcript/36981|m.11162 | UnnamedSample_HQ_transcript/36981 | Coverage 0.975 too low. | 5d79fcd5cbde196f3da437c5e891b8bc | 357 | Pfam | PF03949 | Malic enzyme, NAD binding domain | 42 | 295 | 2.5E-96 | T | 22-09-2020 | IPR012302 | Malic enzyme, NAD-binding |
| UnnamedSample_HQ_transcript/30082|m.9495 | UnnamedSample_HQ_transcript/30082 | Coverage 0.965 too low. | 5d79fcd5cbde196f3da437c5e891b8bc | 357 | Pfam | PF00390 | Malic enzyme, N-terminal domain | 1 | 32 | 4.9E-6 | T | 22-09-2020 | IPR012301 | Malic enzyme, N-terminal domain |
| UnnamedSample_HQ_transcript/30082|m.9495 | UnnamedSample_HQ_transcript/30082 | Coverage 0.965 too low. | 5d79fcd5cbde196f3da437c5e891b8bc | 357 | Pfam | PF03949 | Malic enzyme, NAD binding domain | 42 | 295 | 2.5E-96 | T | 22-09-2020 | IPR012302 | Malic enzyme, NAD-binding |
| UnnamedSample_HQ_transcript/87796|m.20906 | UnnamedSample_HQ_transcript/87796 | Identity 0.589 too low. | f104dba016cb83bb2d1cf4114bbec027 | 391 | Pfam | PF01431 | Peptidase family M13 | 183 | 387 | 1.6E-52 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/87796|m.20906 | UnnamedSample_HQ_transcript/87796 | Identity 0.589 too low. | f104dba016cb83bb2d1cf4114bbec027 | 391 | Pfam | PF05649 | Peptidase family M13 | 17 | 123 | 1.6E-19 | T | 22-09-2020 | IPR008753 | Peptidase M13, N-terminal domain |
| UnnamedSample_HQ_transcript/91318|m.21447 | UnnamedSample_HQ_transcript/91318 | Identity 0.588 too low. | f104dba016cb83bb2d1cf4114bbec027 | 391 | Pfam | PF01431 | Peptidase family M13 | 183 | 387 | 1.6E-52 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/91318|m.21447 | UnnamedSample_HQ_transcript/91318 | Identity 0.588 too low. | f104dba016cb83bb2d1cf4114bbec027 | 391 | Pfam | PF05649 | Peptidase family M13 | 17 | 123 | 1.6E-19 | T | 22-09-2020 | IPR008753 | Peptidase M13, N-terminal domain |
| UnnamedSample_HQ_transcript/17689|m.6219 | UnnamedSample_HQ_transcript/17689 | Coverage 0.745 too low. | d63ffffe3256cd6445ead646ed55d2f1 | 820 | Pfam | PF00168 | C2 domain | 662 | 780 | 8.6E-7 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/22022|m.7431 | UnnamedSample_HQ_transcript/22022 | Coverage 0.728 too low. | d63ffffe3256cd6445ead646ed55d2f1 | 820 | Pfam | PF00168 | C2 domain | 662 | 780 | 8.6E-7 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/58556|m.15765 | UnnamedSample_HQ_transcript/58556 | Coverage 0.674 too low. | b445e2bf2260096b442304f7c5745fb2 | 444 | Pfam | PF00397 | WW domain | 184 | 210 | 2.7E-9 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/65384|m.17095 | UnnamedSample_HQ_transcript/65384 | Coverage 0.186 too low. | f26a41791a6eade71847b90893eff29c | 477 | Pfam | PF00012 | Hsp70 protein | 3 | 350 | 6.3E-51 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/90302|m.21297 | UnnamedSample_HQ_transcript/90302 | Coverage 0.487 too low. | c2b294ca6eceddb5dec9a937f1325fb2 | 255 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 75 | 110 | 6.2E-11 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/90302|m.21297 | UnnamedSample_HQ_transcript/90302 | Coverage 0.487 too low. | c2b294ca6eceddb5dec9a937f1325fb2 | 255 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 112 | 147 | 8.0E-12 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/90302|m.21297 | UnnamedSample_HQ_transcript/90302 | Coverage 0.487 too low. | c2b294ca6eceddb5dec9a937f1325fb2 | 255 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 160 | 195 | 6.8E-12 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/90302|m.21297 | UnnamedSample_HQ_transcript/90302 | Coverage 0.487 too low. | c2b294ca6eceddb5dec9a937f1325fb2 | 255 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 24 | 58 | 4.5E-7 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/90302|m.21297 | UnnamedSample_HQ_transcript/90302 | Coverage 0.487 too low. | c2b294ca6eceddb5dec9a937f1325fb2 | 255 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 202 | 237 | 9.2E-9 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/24108|m.7973 | UnnamedSample_HQ_transcript/24108 | Coverage 0.836 too low. | 1bf36242c3788bc1378579f05617b557 | 888 | Pfam | PF07690 | Major Facilitator Superfamily | 97 | 280 | 4.1E-23 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/94647|m.21895 | UnnamedSample_HQ_transcript/94647 | Coverage 0.445 too low. | e8a42a68fd3a2ebf93f14e5ad2deaef8 | 148 | Pfam | PF12295 | Symplekin tight junction protein C terminal | 2 | 79 | 2.1E-32 | T | 22-09-2020 | IPR022075 | Symplekin C-terminal |
| UnnamedSample_HQ_transcript/69027|m.17766 | UnnamedSample_HQ_transcript/69027 | Coverage 0.973 too low. | edbfb7104883ad089be01d963be05178 | 523 | Pfam | PF09326 | NADH-ubiquinone oxidoreductase subunit G, C-terminal | 455 | 506 | 6.5E-13 | T | 22-09-2020 | IPR015405 | NADH-quinone oxidoreductase, chain G, C-terminal |
| UnnamedSample_HQ_transcript/69027|m.17766 | UnnamedSample_HQ_transcript/69027 | Coverage 0.973 too low. | edbfb7104883ad089be01d963be05178 | 523 | Pfam | PF00384 | Molybdopterin oxidoreductase | 98 | 424 | 9.9E-69 | T | 22-09-2020 | IPR006656 | Molybdopterin oxidoreductase |
| UnnamedSample_HQ_transcript/80580|m.19814 | UnnamedSample_HQ_transcript/80580 | Coverage 0.718 too low. | a9006e40a5109cd410ee417d0ccb38e0 | 446 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 1 | 433 | 4.1E-167 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/53034|m.14650 | UnnamedSample_HQ_transcript/53034 | Coverage 0.983 too low. | 25f7a48df83004d0a79e87bce69edec2 | 383 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 18 | 379 | 1.5E-102 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/13115|m.4848 | UnnamedSample_HQ_transcript/13115 | Coverage 0.987 too low. | 25e771bbab29638a046dc1a268cc9ef5 | 458 | Pfam | PF18141 | Domain of unknown function (DUF5599) | 304 | 394 | 2.5E-28 | T | 22-09-2020 | IPR040812 | Domain of unknown function DUF5599 |
| UnnamedSample_HQ_transcript/13115|m.4848 | UnnamedSample_HQ_transcript/13115 | Coverage 0.987 too low. | 25e771bbab29638a046dc1a268cc9ef5 | 458 | Pfam | PF09416 | RNA helicase (UPF2 interacting domain) | 102 | 252 | 4.1E-74 | T | 22-09-2020 | IPR018999 | RNA helicase UPF1, UPF2-interacting domain |
| UnnamedSample_HQ_transcript/888|m.583 | UnnamedSample_HQ_transcript/888 | Unmapped. | b83405f6e2e5b8aaf03742d949e51130 | 1760 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 1394 | 1719 | 2.6E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/888|m.583 | UnnamedSample_HQ_transcript/888 | Unmapped. | b83405f6e2e5b8aaf03742d949e51130 | 1760 | Pfam | PF00910 | RNA helicase | 332 | 440 | 6.5E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/86325|m.20694 | UnnamedSample_HQ_transcript/86325 | Unmapped. | b14a988227d30a16514af7ce13dbb065 | 247 | Pfam | PF04959 | Arsenite-resistance protein 2 | 35 | 230 | 3.8E-55 | T | 22-09-2020 | IPR007042 | SERRATE/Ars2 , C-terminal |
| UnnamedSample_HQ_transcript/86780|m.20770 | UnnamedSample_HQ_transcript/86780 | Coverage 0.926 too low. | 7c67e98787368715f2fabe19bdeffc8f | 250 | Pfam | PF00006 | ATP synthase alpha/beta family, nucleotide-binding domain | 1 | 88 | 6.0E-38 | T | 22-09-2020 | IPR000194 | ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain |
| UnnamedSample_HQ_transcript/29195|m.9276 | UnnamedSample_HQ_transcript/29195 | Coverage 0.716 too low. | 0f31fa82e7b67ef234ee21581d684197 | 565 | Pfam | PF00351 | Biopterin-dependent aromatic amino acid hydroxylase | 228 | 557 | 7.0E-168 | T | 22-09-2020 | IPR019774 | Aromatic amino acid hydroxylase, C-terminal |
| UnnamedSample_HQ_transcript/68741|m.17717 | UnnamedSample_HQ_transcript/68741 | Coverage 0.962 too low. | 0f31fa82e7b67ef234ee21581d684197 | 565 | Pfam | PF00351 | Biopterin-dependent aromatic amino acid hydroxylase | 228 | 557 | 7.0E-168 | T | 22-09-2020 | IPR019774 | Aromatic amino acid hydroxylase, C-terminal |
| UnnamedSample_HQ_transcript/46779|m.13318 | UnnamedSample_HQ_transcript/46779 | Coverage 0.672 too low. | 0f31fa82e7b67ef234ee21581d684197 | 565 | Pfam | PF00351 | Biopterin-dependent aromatic amino acid hydroxylase | 228 | 557 | 7.0E-168 | T | 22-09-2020 | IPR019774 | Aromatic amino acid hydroxylase, C-terminal |
| UnnamedSample_HQ_transcript/84684|m.20444 | UnnamedSample_HQ_transcript/84684 | Coverage 0.969 too low. | 61faae6937b96f5049796728e2fb8055 | 371 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 90 | 147 | 6.2E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/84684|m.20444 | UnnamedSample_HQ_transcript/84684 | Coverage 0.969 too low. | 61faae6937b96f5049796728e2fb8055 | 371 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 36 | 94 | 6.7E-10 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/84684|m.20444 | UnnamedSample_HQ_transcript/84684 | Coverage 0.969 too low. | 61faae6937b96f5049796728e2fb8055 | 371 | Pfam | PF01410 | Fibrillar collagen C-terminal domain | 169 | 370 | 1.7E-58 | T | 22-09-2020 | IPR000885 | Fibrillar collagen, C-terminal |
| UnnamedSample_HQ_transcript/107124|m.23478 | UnnamedSample_HQ_transcript/107124 | Coverage 0.114 too low. | 26e1a83498c8255a72787f2774936355 | 264 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 126 | 209 | 1.1E-9 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/116853|m.24566 | UnnamedSample_HQ_transcript/116853 | Coverage 0.177 too low. | ab57d14f4f0f46965a2e85e46add9349 | 147 | Pfam | PF00240 | Ubiquitin family | 3 | 74 | 2.1E-34 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/116853|m.24566 | UnnamedSample_HQ_transcript/116853 | Coverage 0.177 too low. | ab57d14f4f0f46965a2e85e46add9349 | 147 | Pfam | PF00240 | Ubiquitin family | 79 | 124 | 1.1E-11 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/19848|m.6824 | UnnamedSample_HQ_transcript/19848 | Coverage 0.910 too low. | d7bcb13fcb6064658818577b55078cff | 918 | Pfam | PF11232 | Mediator complex subunit 25 PTOV activation and synapsin 2 | 557 | 705 | 2.4E-53 | T | 22-09-2020 | IPR021394 | Mediator complex, subunit Med25, PTOV domain |
| UnnamedSample_HQ_transcript/19848|m.6824 | UnnamedSample_HQ_transcript/19848 | Coverage 0.910 too low. | d7bcb13fcb6064658818577b55078cff | 918 | Pfam | PF11265 | Mediator complex subunit 25 von Willebrand factor type A | 11 | 217 | 3.8E-76 | T | 22-09-2020 | IPR021419 | Mediator complex, subunit Med25, von Willebrand factor type A |
| UnnamedSample_HQ_transcript/22212|m.7488 | UnnamedSample_HQ_transcript/22212 | Coverage 0.932 too low. | d7bcb13fcb6064658818577b55078cff | 918 | Pfam | PF11232 | Mediator complex subunit 25 PTOV activation and synapsin 2 | 557 | 705 | 2.4E-53 | T | 22-09-2020 | IPR021394 | Mediator complex, subunit Med25, PTOV domain |
| UnnamedSample_HQ_transcript/22212|m.7488 | UnnamedSample_HQ_transcript/22212 | Coverage 0.932 too low. | d7bcb13fcb6064658818577b55078cff | 918 | Pfam | PF11265 | Mediator complex subunit 25 von Willebrand factor type A | 11 | 217 | 3.8E-76 | T | 22-09-2020 | IPR021419 | Mediator complex, subunit Med25, von Willebrand factor type A |
| UnnamedSample_HQ_transcript/64144|m.16868 | UnnamedSample_HQ_transcript/64144 | Coverage 0.950 too low. | 9f35dc7060f281342e050bb036d03ef5 | 575 | Pfam | PF00262 | Calreticulin family | 57 | 430 | 2.7E-148 | T | 22-09-2020 | IPR001580 | Calreticulin/calnexin |
| UnnamedSample_HQ_transcript/42634|m.12399 | UnnamedSample_HQ_transcript/42634 | Coverage 0.515 too low. | 8c7174b04c58ed979ac4d418e7578430 | 311 | Pfam | PF00595 | PDZ domain | 62 | 133 | 1.2E-18 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/12087|m.4521 | UnnamedSample_HQ_transcript/12087 | Coverage 0.761 too low. | d12af082ff1d18f697a0004321e0503f | 847 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 28 | 161 | 4.1E-26 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/28588|m.9112 | UnnamedSample_HQ_transcript/28588 | Coverage 0.986 too low. | 4262b111a5a405553f54f6d83542b62b | 424 | Pfam | PF00743 | Flavin-binding monooxygenase-like | 224 | 351 | 6.2E-17 | T | 22-09-2020 | IPR020946 | Flavin monooxygenase-like |
| UnnamedSample_HQ_transcript/28588|m.9112 | UnnamedSample_HQ_transcript/28588 | Coverage 0.986 too low. | 4262b111a5a405553f54f6d83542b62b | 424 | Pfam | PF00743 | Flavin-binding monooxygenase-like | 2 | 215 | 1.8E-35 | T | 22-09-2020 | IPR020946 | Flavin monooxygenase-like |
| UnnamedSample_HQ_transcript/11209|m.4225 | UnnamedSample_HQ_transcript/11209 | Coverage 0.980 too low. | 66e26c622a539bd07ba4d58b40702e1a | 1301 | Pfam | PF00053 | Laminin EGF domain | 824 | 869 | 1.5E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11209|m.4225 | UnnamedSample_HQ_transcript/11209 | Coverage 0.980 too low. | 66e26c622a539bd07ba4d58b40702e1a | 1301 | Pfam | PF00053 | Laminin EGF domain | 281 | 325 | 2.4E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11209|m.4225 | UnnamedSample_HQ_transcript/11209 | Coverage 0.980 too low. | 66e26c622a539bd07ba4d58b40702e1a | 1301 | Pfam | PF00053 | Laminin EGF domain | 770 | 821 | 8.1E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11209|m.4225 | UnnamedSample_HQ_transcript/11209 | Coverage 0.980 too low. | 66e26c622a539bd07ba4d58b40702e1a | 1301 | Pfam | PF00053 | Laminin EGF domain | 225 | 272 | 1.8E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11209|m.4225 | UnnamedSample_HQ_transcript/11209 | Coverage 0.980 too low. | 66e26c622a539bd07ba4d58b40702e1a | 1301 | Pfam | PF00053 | Laminin EGF domain | 164 | 212 | 7.5E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11209|m.4225 | UnnamedSample_HQ_transcript/11209 | Coverage 0.980 too low. | 66e26c622a539bd07ba4d58b40702e1a | 1301 | Pfam | PF00053 | Laminin EGF domain | 715 | 763 | 5.5E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11209|m.4225 | UnnamedSample_HQ_transcript/11209 | Coverage 0.980 too low. | 66e26c622a539bd07ba4d58b40702e1a | 1301 | Pfam | PF00053 | Laminin EGF domain | 576 | 596 | 0.011 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11209|m.4225 | UnnamedSample_HQ_transcript/11209 | Coverage 0.980 too low. | 66e26c622a539bd07ba4d58b40702e1a | 1301 | Pfam | PF00053 | Laminin EGF domain | 660 | 705 | 4.3E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11209|m.4225 | UnnamedSample_HQ_transcript/11209 | Coverage 0.980 too low. | 66e26c622a539bd07ba4d58b40702e1a | 1301 | Pfam | PF00053 | Laminin EGF domain | 611 | 657 | 3.4E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11209|m.4225 | UnnamedSample_HQ_transcript/11209 | Coverage 0.980 too low. | 66e26c622a539bd07ba4d58b40702e1a | 1301 | Pfam | PF00053 | Laminin EGF domain | 872 | 915 | 5.9E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11209|m.4225 | UnnamedSample_HQ_transcript/11209 | Coverage 0.980 too low. | 66e26c622a539bd07ba4d58b40702e1a | 1301 | Pfam | PF00053 | Laminin EGF domain | 328 | 378 | 5.7E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11209|m.4225 | UnnamedSample_HQ_transcript/11209 | Coverage 0.980 too low. | 66e26c622a539bd07ba4d58b40702e1a | 1301 | Pfam | PF00052 | Laminin B (Domain IV) | 444 | 575 | 1.1E-26 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/11209|m.4225 | UnnamedSample_HQ_transcript/11209 | Coverage 0.980 too low. | 66e26c622a539bd07ba4d58b40702e1a | 1301 | Pfam | PF00055 | Laminin N-terminal (Domain VI) | 5 | 161 | 4.3E-45 | T | 22-09-2020 | IPR008211 | Laminin, N-terminal |
| UnnamedSample_HQ_transcript/8787|m.3446 | UnnamedSample_HQ_transcript/8787 | Unmapped. | 06b23aa84a2663703505c97b38624986 | 1235 | Pfam | PF08762 | CRPV capsid protein like | 887 | 1097 | 6.0E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/116594|m.24544 | UnnamedSample_HQ_transcript/116594 | Coverage 0.989 too low. | 57ccfe0c206fb8a0b9fef31ce2a0a785 | 184 | Pfam | PF09809 | Mitochondrial ribosomal protein L27 | 41 | 147 | 3.5E-18 | T | 22-09-2020 | IPR019189 | Ribosomal protein L27/L41, mitochondrial |
| UnnamedSample_HQ_transcript/37420|m.11254 | UnnamedSample_HQ_transcript/37420 | Coverage 0.162 too low. | bd53e7a20b78c76218132cea51ca5c3c | 678 | Pfam | PF01414 | Delta serrate ligand | 2 | 64 | 1.1E-21 | T | 22-09-2020 | IPR001774 | Delta/Serrate/lag-2 (DSL) protein |
| UnnamedSample_HQ_transcript/37420|m.11254 | UnnamedSample_HQ_transcript/37420 | Coverage 0.162 too low. | bd53e7a20b78c76218132cea51ca5c3c | 678 | Pfam | PF00008 | EGF-like domain | 367 | 399 | 1.3E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/37420|m.11254 | UnnamedSample_HQ_transcript/37420 | Coverage 0.162 too low. | bd53e7a20b78c76218132cea51ca5c3c | 678 | Pfam | PF00008 | EGF-like domain | 329 | 358 | 4.5E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/37420|m.11254 | UnnamedSample_HQ_transcript/37420 | Coverage 0.162 too low. | bd53e7a20b78c76218132cea51ca5c3c | 678 | Pfam | PF00008 | EGF-like domain | 213 | 242 | 2.2E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/37420|m.11254 | UnnamedSample_HQ_transcript/37420 | Coverage 0.162 too low. | bd53e7a20b78c76218132cea51ca5c3c | 678 | Pfam | PF00008 | EGF-like domain | 135 | 165 | 4.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/37420|m.11254 | UnnamedSample_HQ_transcript/37420 | Coverage 0.162 too low. | bd53e7a20b78c76218132cea51ca5c3c | 678 | Pfam | PF00008 | EGF-like domain | 175 | 204 | 1.4E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/37420|m.11254 | UnnamedSample_HQ_transcript/37420 | Coverage 0.162 too low. | bd53e7a20b78c76218132cea51ca5c3c | 678 | Pfam | PF00008 | EGF-like domain | 251 | 283 | 6.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/37420|m.11254 | UnnamedSample_HQ_transcript/37420 | Coverage 0.162 too low. | bd53e7a20b78c76218132cea51ca5c3c | 678 | Pfam | PF00008 | EGF-like domain | 291 | 320 | 4.5E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/20814|m.7095 | UnnamedSample_HQ_transcript/20814 | Coverage 0.149 too low. | 238f873b36b9bc859ee8c7ec856ee34f | 336 | Pfam | PF02145 | Rap/ran-GAP | 1 | 83 | 1.9E-19 | T | 22-09-2020 | IPR000331 | Rap GTPase activating protein domain |
| UnnamedSample_HQ_transcript/53544|m.14748 | UnnamedSample_HQ_transcript/53544 | Coverage 0.939 too low. | 238f873b36b9bc859ee8c7ec856ee34f | 336 | Pfam | PF02145 | Rap/ran-GAP | 1 | 83 | 1.9E-19 | T | 22-09-2020 | IPR000331 | Rap GTPase activating protein domain |
| UnnamedSample_HQ_transcript/101160|m.22770 | UnnamedSample_HQ_transcript/101160 | Coverage 0.987 too low. | d64446b62896b354f5d0c4a5dc062ed3 | 259 | Pfam | PF02171 | Piwi domain | 1 | 244 | 7.2E-71 | T | 22-09-2020 | IPR003165 | Piwi domain |
| UnnamedSample_HQ_transcript/6896|m.2826 | UnnamedSample_HQ_transcript/6896 | Coverage 0.785 too low. | a3229fed50d895acfaae5a97e03f1456 | 378 | Pfam | PF01476 | LysM domain | 12 | 54 | 2.2E-9 | T | 22-09-2020 | IPR018392 | LysM domain |
| UnnamedSample_HQ_transcript/105301|m.23263 | UnnamedSample_HQ_transcript/105301 | Coverage 0.955 too low. | 1e42b770f8f34fcae2639295a3140e20 | 285 | Pfam | PF00170 | bZIP transcription factor | 67 | 127 | 9.9E-14 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/3202|m.1524 | UnnamedSample_HQ_transcript/3202 | Coverage 0.322 too low. | 33fff83ad3ea984a90c0034006b6bd0f | 1036 | Pfam | PF16209 | Phospholipid-translocating ATPase N-terminal | 29 | 75 | 8.5E-18 | T | 22-09-2020 | IPR032631 | P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/3202|m.1524 | UnnamedSample_HQ_transcript/3202 | Coverage 0.322 too low. | 33fff83ad3ea984a90c0034006b6bd0f | 1036 | Pfam | PF13246 | Cation transport ATPase (P-type) | 445 | 527 | 3.1E-6 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/3202|m.1524 | UnnamedSample_HQ_transcript/3202 | Coverage 0.322 too low. | 33fff83ad3ea984a90c0034006b6bd0f | 1036 | Pfam | PF16212 | Phospholipid-translocating P-type ATPase C-terminal | 772 | 1019 | 4.0E-58 | T | 22-09-2020 | IPR032630 | P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/8437|m.3334 | UnnamedSample_HQ_transcript/8437 | Identity 0.695 too low. | 9313197367280cafb1af82d99307ea1a | 1183 | Pfam | PF12057 | BCL2-associated athanogene 6 | 2 | 93 | 5.3E-20 | T | 22-09-2020 | IPR021925 | Large proline-rich protein BAG6 |
| UnnamedSample_HQ_transcript/62992|m.16626 | UnnamedSample_HQ_transcript/62992 | Coverage 0.984 too low. | ce4db4e57d83b6b4b1bd1e8cf1f6f94f | 358 | Pfam | PF02958 | Ecdysteroid kinase | 1 | 259 | 5.4E-54 | T | 22-09-2020 | IPR004119 | Ecdysteroid kinase-like |
| UnnamedSample_HQ_transcript/93897|m.21798 | UnnamedSample_HQ_transcript/93897 | Coverage 0.984 too low. | ce4db4e57d83b6b4b1bd1e8cf1f6f94f | 358 | Pfam | PF02958 | Ecdysteroid kinase | 1 | 259 | 5.4E-54 | T | 22-09-2020 | IPR004119 | Ecdysteroid kinase-like |
| UnnamedSample_HQ_transcript/58287|m.15710 | UnnamedSample_HQ_transcript/58287 | Coverage 0.989 too low. | ce4db4e57d83b6b4b1bd1e8cf1f6f94f | 358 | Pfam | PF02958 | Ecdysteroid kinase | 1 | 259 | 5.4E-54 | T | 22-09-2020 | IPR004119 | Ecdysteroid kinase-like |
| UnnamedSample_HQ_transcript/68084|m.17594 | UnnamedSample_HQ_transcript/68084 | Identity 0.930 too low. | ce4db4e57d83b6b4b1bd1e8cf1f6f94f | 358 | Pfam | PF02958 | Ecdysteroid kinase | 1 | 259 | 5.4E-54 | T | 22-09-2020 | IPR004119 | Ecdysteroid kinase-like |
| UnnamedSample_HQ_transcript/39306|m.11712 | UnnamedSample_HQ_transcript/39306 | Identity 0.938 too low. | 8bbf8046afb6609ee0952be701edd1f4 | 807 | Pfam | PF05028 | Poly (ADP-ribose) glycohydrolase (PARG) | 72 | 346 | 1.9E-46 | T | 22-09-2020 | IPR007724 | Poly(ADP-ribose) glycohydrolase |
| UnnamedSample_HQ_transcript/39306|m.11712 | UnnamedSample_HQ_transcript/39306 | Identity 0.938 too low. | 8bbf8046afb6609ee0952be701edd1f4 | 807 | Pfam | PF05028 | Poly (ADP-ribose) glycohydrolase (PARG) | 608 | 737 | 2.2E-13 | T | 22-09-2020 | IPR007724 | Poly(ADP-ribose) glycohydrolase |
| UnnamedSample_HQ_transcript/5968|m.2530 | UnnamedSample_HQ_transcript/5968 | Coverage 0.781 too low. | 4c2864c42d3debd1c3f1f1bfd8d5e2c3 | 655 | Pfam | PF02257 | RFX DNA-binding domain | 139 | 214 | 7.8E-32 | T | 22-09-2020 | IPR003150 | DNA-binding RFX-type winged-helix domain |
| UnnamedSample_HQ_transcript/40314|m.11913 | UnnamedSample_HQ_transcript/40314 | Identity 0.941 too low. | ef0c51aa352d27d5bfdb8af667bf368d | 598 | Pfam | PF12210 | Hepatocyte growth factor-regulated tyrosine kinase substrate | 166 | 258 | 2.9E-40 | T | 22-09-2020 | IPR024641 | Hepatocyte growth factor-regulated tyrosine kinase substrate, helical domain |
| UnnamedSample_HQ_transcript/34451|m.10593 | UnnamedSample_HQ_transcript/34451 | Coverage 0.163 too low. | 2a8a5918ca9c98bde6d9b595bf7cc409 | 637 | Pfam | PF00069 | Protein kinase domain | 51 | 302 | 9.2E-76 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/85800|m.20622 | UnnamedSample_HQ_transcript/85800 | Identity 0.350 too low. | 9688720204f821fceb44731fea9a020e | 418 | Pfam | PF08662 | Eukaryotic translation initiation factor eIF2A | 213 | 408 | 2.7E-78 | T | 22-09-2020 | IPR013979 | Translation initiation factor, beta propellor-like domain |
| UnnamedSample_HQ_transcript/74908|m.18814 | UnnamedSample_HQ_transcript/74908 | Coverage 0.780 too low. | c07f9540b9b9d42517c5025357705a87 | 525 | Pfam | PF12936 | KRI1-like family C-terminal | 458 | 523 | 2.3E-25 | T | 22-09-2020 | IPR024626 | Kri1-like, C-terminal |
| UnnamedSample_HQ_transcript/74908|m.18814 | UnnamedSample_HQ_transcript/74908 | Coverage 0.780 too low. | c07f9540b9b9d42517c5025357705a87 | 525 | Pfam | PF05178 | KRI1-like family | 283 | 374 | 9.0E-17 | T | 22-09-2020 | IPR018034 | KRR1 interacting protein 1 |
| UnnamedSample_HQ_transcript/20581|m.7030 | UnnamedSample_HQ_transcript/20581 | Coverage 0.879 too low. | 95153a56c4a74b6683a0e8ac95854c6b | 560 | Pfam | PF03133 | Tubulin-tyrosine ligase family | 7 | 258 | 2.4E-83 | T | 22-09-2020 | IPR004344 | Tubulin-tyrosine ligase/Tubulin polyglutamylase |
| UnnamedSample_HQ_transcript/61550|m.16359 | UnnamedSample_HQ_transcript/61550 | Unmapped. | 6fb88d87831a5304587a9ff75ea6d42f | 486 | Pfam | PF02913 | FAD linked oxidases, C-terminal domain | 241 | 484 | 1.4E-58 | T | 22-09-2020 | IPR004113 | FAD-linked oxidase, C-terminal |
| UnnamedSample_HQ_transcript/61550|m.16359 | UnnamedSample_HQ_transcript/61550 | Unmapped. | 6fb88d87831a5304587a9ff75ea6d42f | 486 | Pfam | PF01565 | FAD binding domain | 68 | 204 | 5.7E-33 | T | 22-09-2020 | IPR006094 | FAD linked oxidase, N-terminal |
| UnnamedSample_HQ_transcript/60399|m.16142 | UnnamedSample_HQ_transcript/60399 | Unmapped. | 6fb88d87831a5304587a9ff75ea6d42f | 486 | Pfam | PF02913 | FAD linked oxidases, C-terminal domain | 241 | 484 | 1.4E-58 | T | 22-09-2020 | IPR004113 | FAD-linked oxidase, C-terminal |
| UnnamedSample_HQ_transcript/60399|m.16142 | UnnamedSample_HQ_transcript/60399 | Unmapped. | 6fb88d87831a5304587a9ff75ea6d42f | 486 | Pfam | PF01565 | FAD binding domain | 68 | 204 | 5.7E-33 | T | 22-09-2020 | IPR006094 | FAD linked oxidase, N-terminal |
| UnnamedSample_HQ_transcript/42110|m.12288 | UnnamedSample_HQ_transcript/42110 | Coverage 0.910 too low. | 6674d147485e22f4308036435a60999f | 695 | Pfam | PF00013 | KH domain | 231 | 295 | 2.5E-17 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/42110|m.12288 | UnnamedSample_HQ_transcript/42110 | Coverage 0.910 too low. | 6674d147485e22f4308036435a60999f | 695 | Pfam | PF00013 | KH domain | 113 | 174 | 5.7E-17 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/42110|m.12288 | UnnamedSample_HQ_transcript/42110 | Coverage 0.910 too low. | 6674d147485e22f4308036435a60999f | 695 | Pfam | PF00013 | KH domain | 342 | 404 | 5.3E-15 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/42110|m.12288 | UnnamedSample_HQ_transcript/42110 | Coverage 0.910 too low. | 6674d147485e22f4308036435a60999f | 695 | Pfam | PF09005 | Domain of unknown function (DUF1897) | 488 | 522 | 7.3E-20 | T | 22-09-2020 | IPR015096 | Far upstream element-binding protein, C-terminal |
| UnnamedSample_HQ_transcript/42110|m.12288 | UnnamedSample_HQ_transcript/42110 | Coverage 0.910 too low. | 6674d147485e22f4308036435a60999f | 695 | Pfam | PF09005 | Domain of unknown function (DUF1897) | 576 | 609 | 2.6E-17 | T | 22-09-2020 | IPR015096 | Far upstream element-binding protein, C-terminal |
| UnnamedSample_HQ_transcript/53000|m.14643 | UnnamedSample_HQ_transcript/53000 | Coverage 0.435 too low. | 0678399dcc3cf06e20d1aae99e12117e | 271 | Pfam | PF02121 | Phosphatidylinositol transfer protein | 1 | 252 | 2.2E-117 | T | 22-09-2020 | IPR001666 | Phosphatidylinositol transfer protein |
| UnnamedSample_HQ_transcript/90390|m.21311 | UnnamedSample_HQ_transcript/90390 | Coverage 0.941 too low. | 3fc7d26bc797adfa00ce11548597de37 | 323 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 277 | 322 | 0.0055 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/90390|m.21311 | UnnamedSample_HQ_transcript/90390 | Coverage 0.941 too low. | 3fc7d26bc797adfa00ce11548597de37 | 323 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 216 | 261 | 0.0059 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/90390|m.21311 | UnnamedSample_HQ_transcript/90390 | Coverage 0.941 too low. | 3fc7d26bc797adfa00ce11548597de37 | 323 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 34 | 79 | 0.099 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/90390|m.21311 | UnnamedSample_HQ_transcript/90390 | Coverage 0.941 too low. | 3fc7d26bc797adfa00ce11548597de37 | 323 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 154 | 200 | 0.024 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/96351|m.22145 | UnnamedSample_HQ_transcript/96351 | Coverage 0.938 too low. | 3fc7d26bc797adfa00ce11548597de37 | 323 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 277 | 322 | 0.0055 | T | 22-09-2020 | IPR002350 | Kazal domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
